Antimicrobials
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
196
NCT02284555
Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)
Phase: Phase 4
Role: Lead Sponsor
Start: Aug 31, 2014
Completion: Nov 30, 2014
NCT02282605
Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects
Phase: Phase 1/2
Start: Sep 30, 2014
NCT03915470
Effect of Exeporfinium Chloride (XF-73) Gel on Nasal S.Aureus in Patients at Risk of Post-op Staphylococcal Infection
Phase: Phase 2
Start: Aug 29, 2019
Completion: Mar 29, 2021
Loading map...